Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROBES study of oral micronized progesterone versus norethisterone acetate with oral estrogen for menopausal hormone therapy
2024-520435-33-00Phase 3Authorised
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vasomotor symptoms comparing Estradiol + micronized progesterone with Estradiol + norethisterone acetate (2 arms). Primary endpoint: Percentage change in mammographic density. Planned start Jan 2025; status: authorised.
02
Drugs
progesteronenorethisterone acetateestradiol
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on 2024-520435-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520435-33-00.